The cancer diagnostics company has gone into a trading halt following an adverse decision on reimbursement of its US bladder tests.
Company says shareholders can expect an improved dividend as increased generation comes on stream , though that's diluted by spending on its Wairakei replacement project.
The NZX-listed milk processor faces receivership if special meeting vote does not approve $130m shareholder loan from Bright Dairy.
It may be ‘back to basics’ for port operations, but it’s not cheap as the country’s second-busiest port looks to secure $1.1b in profits over the next decade.
Growth pipeline drives revaluation of 48%-owned Australian data centre business.
New Talisman Gold Mines shares resume trading after suspension as fresh loan facilities mollify auditor.
Shares in the company have doubled on the ASX over the past year on hopes for the Bendigo-Ophir gold project.
Analysts say company claims of benefits to Vista and its customers from migration to the cloud bear out, even if it will take longer for all of them to get on board.
Telematics company signs its largest Australasian customer with deal for up to 11,000 vehicles.
The horticulture company’s share price raised questions at the annual meeting.